The Prognostic Value of Biomarkers in Non-ST-Elevation Acute Coronary Syndrome Patients that are Treated by an Early Invasive Strategy: Insights from the OPTIMA-2 Trial by Nick D. Fagel, Maarten A. Vink, Antonius A.C.M. Heestermans, Robert K. Riezebos

Get full text

4‐Fluoroamphetamine (4‐FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis by Femke M. J. Gresnigt, Anouk Snik, Eric J. F. Franssen, Joost W. Vanhommerig, Dylan W. deLange, Robert K. Riezebos

Get full text

Recreational drug use among young, hospitalized patients with acute coronary syndrome: A retrospective study by Femke M.J. Gresnigt, Meike Hulshof, Eric J.F. Franssen, Joost W. Vanhommerig, Dylan W. de Lange, Robert K. Riezebos

Get full text

The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial by Nick D. Fagel, Stefan G. J. Leuven, Wouter J. Kikkert, Michelle M. de Leau, Loek van Heerebeek, Robert K. Riezebos

Get full text

Performance of an automated photoplethysmography-based artificial intelligence algorithm to detect atrial fibrillation by Daniel Mol, BSc, Robert K. Riezebos, MD, PhD, Henk A. Marquering, PhD, Marije E. Werner, MD, Trudie C.A. Lobban, MBE, FRCP, Jonas S.S.G. de Jong, MD, PhD, Joris R. de Groot, MD, PhD

Get full text